Company Announcements and Press Releases

Novo Nordisk country sites USA Argentina Australia Austria Belgium Brazil Bulgaria Canada Chile China Croatia Czech Republic Denmark Egypt Estonia Finland France Germany Greece Hungary India Iraq Ireland Israel Italy Japan Korea (Republic) Latvia Lebanon Lithuania Mexico Netherlands New Zealand Norway Pakistan Poland Portugal Romania Russian Federation Serbia Slovak Republic Slovenia South Africa Spain Sweden Switzerland Syria Taiwan Thailand Turkey Ukraine United Kingdom Other Novo Nordisk sites Changing diabetes NovoMedLink DAWN study Hagedorn Research Institute Diabetes4Patients Diabetes Barometer Changing diabetes bus Media prize World diabetes day School challenge Improve Control HRT for HCPs HRT for women HRT congresses & symposia

• News
• Facts about Novo Nordisk
• R&D pipeline
• Download centre
• Diabetes dictionary
• Broadcast room
• Photos
• Subscription
• Victoza® (liraglutide) press room
• Contact

• 
• Print

News

Trading in Novo Nordisk shares by board members, executives and associated persons as reported to Novo Nordisk on 2 February 2010 (3 February 2010)

Read the full announcement in PDF format

In accordance with Section 28a of the Danish Securities Trading Act, Novo Nordisk is required on a daily basis to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons as reported by those persons to Novo Nordisk.

For further information please contact:

Media:	Investors:
Outside North America:	Outside North America:
Elin K Hansen	Klaus Bülow Davidsen
Tel: (+45) 4442 3450	Tel: (+45) 4442 3176
ekh@novonordisk.com	klda@novonordisk.com
	Kasper Roseeuw Poulsen
	Tel: (+45) 4442 4471
	krop@novonordisk.com
In North America:	In North America
Sean Clements	Hans Rommer
Tel: (+1) 609 514 8316	Tel: (+1) 609 919 7937
secl@novonordisk.com	hrmm@novonordisk.com

Company Announcement no 5 / 2010